Trademarks = 1

Forward Citations = 10

Loading Chart...

9 inventors (with patents filed for the assignee):

Vance Gardner (4 out of 7 patents)

John W Jacobs (4 out of 11 patents)

Thomas J Stegmann (3 out of 7 patents)

4. Hon Yu (2 out of 4 patents)

5. Kenneth A Thomas (2 out of 10 patents)

6. Tugan Muftuler (2 out of 4 patents)

7. Shadfar Bahri (2 out of 4 patents)

8. Mickael Flaa (2 out of 3 patents)

9. Laurence R Meyerson (2 out of 3 patents)

5 patents: Sort by Forward Citations

1. 10624952 - Systems and methods for angiogenic treatment in wound healing (2020-04-21),

2. 10433783 - Therapeutic angiogenesis for treating erectile conditions (2019-10-08),

3. 9968292 - Therapeutic angiogenesis for treating erectile conditions (2018-05-15),

4. 8983570 - Therapeutic angiogenesis for treatment of the spine (2015-03-17),

5. 7252818 - Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis (2007-08-07),

Company Overview

Cardiovascular Biotherapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cardiovascular diseases. With a team of experienced scientists and researchers, we are dedicated to advancing novel treatments that improve the lives of patients with heart conditions. Our goal is to revolutionize the field of cardiovascular medicine through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#224 in Las Vegas, NV

#463 in Nevada

#51,644 in US

Las Vegas, NV, United States of America

Cardiovascular Biotherapeutics, Inc.

Forward Citations = 10

9 inventors:

Vance Gardner (4 out of 7 patents)

John W Jacobs (4 out of 11 patents)

Thomas J Stegmann (3 out of 7 patents)

4. Hon Yu (2 out of 4 patents)

5. Kenneth A Thomas (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cardiovascular Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/cardiovascular-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]